Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Pos...

Saved in:

Published in:	Journal of clinical oncology 30(2012), 35, Seite 4323-4329
Authors and Corporations:	Branford, Susan (Author), Müller, Martin Christian (Author)
Title:	Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib/ Susan Branford, Dong-Wook Kim, Simona Soverini, Ariful Haque, Yaping Shou, Richard C. Woodman, Hagop M. Kantarjian, Giovanni Martinelli, Jerald P. Radich, Giuseppe Saglio, Andreas Hochhaus, Timothy P. Hughes, and Martin C. Müller
Type of Resource:	E-Book Component Part
Language:	English
published:	2012
Series:	: Journal of clinical oncology, 30(2012), 35, Seite 4323-4329 , volume:30
Erscheint auch als:	Branford, Susan, Initial molecular response at 3 months may predict both response and event-free survival at 24 months in imatinib-resistant or -intolerant patients with philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with nilotinib, 2012
Source:	Verbunddaten SWB Lizenzfreie Online-Ressourcen

Internet

Full Text